We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Rtw Biotech Opportunities Ltd | LSE:RTWG | London | Ordinary Share | GG00BKTRRM22 | ORD NPV (GBP) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.50 | -1.44% | 103.00 | 103.00 | 105.00 | 103.00 | 103.00 | 103.00 | 25,781 | 11:03:04 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Trust,ex Ed,religious,charty | 2.17M | -5.29M | -0.0251 | -41.04 | 216.95M |
From Apr 2023 to Apr 2024
TIDMRTW
RNS Number : 9746X
RTW Venture Fund Limited
02 May 2023
LEI: 549300Q7EXQQH6KF7Z84
2 May 2023
RTW Venture Fund Limited
Annual Financial Report
Year ended 31 December 2022
A tagged copy of the above document was submitted to the National Storage Mechanism on 28 April 2023 and is
available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For Further Information:
RTW Investments, LP +44 (0)20 7959 6361 Woody Stileman, Managing Director Krisha McCune, Director, Client Service Buchanan +44 (0)20 7466 5107 Charles Ryland Henry Wilson George Beale Numis +44 (0)20 7260 1000 Freddie Barnfield Nathan Brown Euan Brown BofA Securities +44 (0) 20 7628 1000 Edward Peel Kieran Millar
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACSSSDFFFEDSEII
(END) Dow Jones Newswires
May 02, 2023 02:00 ET (06:00 GMT)
1 Year Rtw Biotech Opportunities Chart |
1 Month Rtw Biotech Opportunities Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
